ORGANOGENESIS HOLDINGS INC. Lease Obligation Incurred
ORGANOGENESIS HOLDINGS INC. (ORGO) reported Lease Obligation Incurred of $1.10 million for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-16.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalLeaseObligationsIncurred · last filed 2021-03-16
- ORGANOGENESIS HOLDINGS INC. lease obligation incurred for the quarter ending 2019-12-31 was $126.00K.
- ORGANOGENESIS HOLDINGS INC. lease obligation incurred for fiscal 2019 was $1.10M.
| Period end | Lease Obligation Incurred 3 month | Lease Obligation Incurred 9 month | Lease Obligation Incurred 12 month |
|---|---|---|---|
| 2019-12-31 | $126.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $1.10M 10-K · filed 2021-03-16 | |
| 2019-09-30 | $973.00K 10-Q · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |